Literature DB >> 21458197

Primary arteriovenous fistula inflow proximalization for patients at high risk for dialysis access-associated ischemic steal syndrome.

William C Jennings1, Robert E Brown, Carmen Ruiz.   

Abstract

Establishing a functional vascular access while minimizing the risk of dialysis access-associated ischemic steal syndrome (DASS) may present a challenging problem in patients with severe peripheral vascular disease where even a low-flow arteriovenous fistula (AVF) may lead to severe symptoms and physical findings of DASS. Proximalization of arterial inflow for an existing vascular access is established as an effective treatment for DASS. We hypothesized that a primary proximal arterial inflow procedure for vascular access in patients judged to be at high risk for DASS would result in a successful hemodialysis access and mitigate the risk of steal syndrome. We report four such patients considered to be at significant risk for DASS after construction of a new vascular access. An axillary artery AVF inflow anastomosis was constructed in each patient. The access outflow configuration varied with the available venous outflow conduit identified during the preoperative ultrasound evaluation. In all four patients in this report, a functional autogenous dialysis access was established without DASS.
Copyright © 2011 Society for Vascular Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21458197     DOI: 10.1016/j.jvs.2011.01.031

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  2 in total

1.  Alternative prosthetic vascular access creation using subscapular artery as inflow to prevent dialysis access related steal syndrome.

Authors:  Dan Song; Sangchul Yun
Journal:  Ann Surg Treat Res       Date:  2015-05-14       Impact factor: 1.859

Review 2.  Operative Techniques to Prevent Dialysis Access-associated Steal Syndrome in High-risk Patients Undergoing Surgery for Hemodialysis Access: A Systematic Review.

Authors:  Fareed A Shaikh; Nadeem Siddiqui; Noman Shahzad; Amna Riaz; Ziad Sophie
Journal:  Cureus       Date:  2019-11-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.